Organoid‐based two‐step drug screening for rapid identification of chemotherapy‐resistant oesophageal squamous cell carcinoma and alternative therapies

Documenti analoghi

• PADI4 facilitates stem‐like properties and cisplatin resistance through upregulating PRMT2/IDs family in oesophageal squamous cell carcinoma
  di: Zeyu Wang, et al.
  Pubblicazione: (2025)
• Integrative analyses of single‐cell and bulk RNA sequencing reveal tumour microenvironment features associated with neoadjuvant immunochemotherapy response in oesophageal squamous cell carcinoma
  di: Xianxian Wu, et al.
  Pubblicazione: (2025)
• Long‐term survival and association of neoadjuvant chemotherapy with or without immunotherapy in resectable esophageal squamous cell carcinoma
  di: Lin Lu, et al.
  Pubblicazione: (2025)
• PARylation of HMGA1 desensitizes esophageal squamous cell carcinoma to olaparib
  di: Xin‐Yuan Lei, et al.
  Pubblicazione: (2024)
• Radiation‐induced extracellular vesicles from cancer‐associated fibroblasts drive oesophageal squamous cell carcinoma metastasis via the miR‐193a‐3p/PTEN/Akt pathway
  di: Yechun Pang, et al.
  Pubblicazione: (2025)